Anticoagulation Forum and CYP2C9

Kim Kinney’s response about monitoring for CYP2C9 polymorphisms reminded me of last summer’s Anticoagulation Forum exchange between…

…Dr. David Garcia, Anticoagulation Forum president and Lawrence J. Lesko, PhD, FCP regarding the FDA’s plan to require information in the Warfarin package insert about genomic testing. There are some differences of opinion about the efficacy of genomic testing and the need for more definitive clinical trials. Kim may want to include this in her presentation this week. Geo.